KeyBanc raised the firm’s price target on Emerson (EMR) to $155 from $150 and keeps an Overweight rating on the shares. The firm met with management and walked away with higher conviction that Emerson remains an underappreciated story with structurally stronger margins and resilient secular growth opportunities following its substantial portfolio transformation into a pure-play Industrial Automation conglomerate.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR: